A Study to Evaluate the Effect of Nandrolone Decanoate in Women With HIV-Associated Weight Loss

PHASE1CompletedINTERVENTIONAL
Enrollment

38

Participants

Timeline

Start Date

Not specified

Study Completion Date

May 31, 2003

Conditions
HIV InfectionsHIV Wasting Syndrome
Interventions
DRUG

Nandrolone decanoate

Trial Locations (22)

10003

Beth Israel Med. Ctr. (Mt. Sinai), New York

14642

Univ. of Rochester ACTG CRS, Rochester

19104

Hosp. of the Univ. of Pennsylvania CRS, Philadelphia

20060

Howard University Hosp., Div. of Infectious Diseases, ACTU, Washington D.C.

21287

Johns Hopkins Adult AIDS CRS, Baltimore

27514

Unc Aids Crs, Chapel Hill

27710

Duke Univ. Med. Ctr. Adult CRS, Durham

45267

Univ. of Cincinnati CRS, Cincinnati

60611

Northwestern University CRS, Chicago

63110

Washington U CRS, St Louis

63112

St. Louis ConnectCare, Infectious Diseases Clinic, St Louis

70112

Tulane Med. Ctr. - Charity Hosp. of New Orleans, ACTU, New Orleans

80045

University of Colorado Hospital CRS, Aurora

90033

USC CRS, Los Angeles

90035

UCLA CARE Center CRS, Los Angeles

92103

Ucsd, Avrc Crs, San Diego

94110

Ucsf Aids Crs, San Francisco

96813

Queens Med. Ctr., Honolulu

96816

Univ. of Hawaii at Manoa, Leahi Hosp., Honolulu

02215

Beth Israel Deaconess Med. Ctr., ACTG CRS, Boston

00935

Puerto Rico-AIDS CRS, San Juan

00936

San Juan City Hosp. PR NICHD CRS, San Juan

All Listed Sponsors
lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

NCT00000854 - A Study to Evaluate the Effect of Nandrolone Decanoate in Women With HIV-Associated Weight Loss | Biotech Hunter | Biotech Hunter